According to Medifast's latest financial reports the company has $0.15 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.15 B | 71.1% |
2022-12-31 | $87.69 M | -19.95% |
2021-12-31 | $0.10 B | -37.22% |
2020-12-31 | $0.17 B | 88.26% |
2019-12-31 | $92.67 M | -8.27% |
2018-12-31 | $0.10 B | 2.23% |
2017-12-31 | $98.83 M | 28.61% |
2016-12-31 | $76.84 M | 14.51% |
2015-12-31 | $67.1 M | 27.48% |
2014-12-31 | $52.64 M | -22.36% |
2013-12-31 | $67.8 M | 13.01% |
2012-12-31 | $59.99 M | 77.5% |
2011-12-31 | $33.8 M | -1.85% |
2010-12-31 | $34.43 M | 111.24% |
2009-12-31 | $16.3 M | 454.49% |
2008-12-31 | $2.94 M | -19.1% |
2007-12-31 | $3.63 M | 38.44% |
2006-12-31 | $2.62 M | -37.26% |
2005-12-31 | $4.18 M | 29.22% |
2004-12-31 | $3.23 M | -50.24% |
2003-12-31 | $6.5 M | 418.49% |
2002-12-31 | $1.25 M | 115.64% |
2001-12-31 | $0.58 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | -36.10% | ๐บ๐ธ USA |
Abeona Therapeutics
ABEO | $52.22 M | -65.19% | ๐บ๐ธ USA |
Bellerophon Therapeutics
BLPH | $4.38 M | -97.08% | ๐บ๐ธ USA |